Bioceres Crop Solutions (BIOX) Stock Forecast, Price Target & Predictions
BIOX Stock Forecast
Bioceres Crop Solutions stock forecast is as follows: an average price target of $13.30 (represents a 94.44% upside from BIOX’s last price of $6.84) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
BIOX Price Target
The average price target for Bioceres Crop Solutions (BIOX) is $13.30 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $12.50. This represents a potential 94.44% upside from BIOX's last price of $6.84.
BIOX Analyst Ratings
According to 3 Wall Street analysts, Bioceres Crop Solutions's rating consensus is 'Buy'. The analyst rating breakdown for BIOX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Bioceres Crop Solutions Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | Kristen Owen | Oppenheimer | $13.00 | $7.51 | 73.10% | 90.06% |
| Sep 11, 2024 | Ben Klieve | Loop Capital Markets | $13.00 | $8.31 | 56.36% | 90.06% |
| Sep 11, 2024 | Ben Klieve | Lake Street | $13.00 | $8.65 | 50.29% | 90.06% |
| Sep 11, 2024 | Austin Moeller | Canaccord Genuity | $12.50 | $8.36 | 49.61% | 82.75% |
| Sep 10, 2024 | Kristen Owen | Oppenheimer | $16.00 | $8.65 | 84.97% | 133.92% |
| Jul 02, 2024 | Scott Fortune | Roth Capital | $15.00 | $11.13 | 34.77% | 119.30% |
The latest Bioceres Crop Solutions stock forecast, released on Oct 21, 2024 by Kristen Owen from Oppenheimer, set a price target of $13.00, which represents a 73.10% increase from the stock price at the time of the forecast ($7.51), and a 90.06% increase from BIOX last price ($6.84).
Bioceres Crop Solutions Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 5 | 6 |
| Avg Price Target | $13.00 | $13.50 | $13.75 |
| Last Closing Price | $6.84 | $6.84 | $6.84 |
| Upside/Downside | 90.06% | 97.37% | 101.02% |
In the current month, the average price target of Bioceres Crop Solutions stock is $13.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 90.06% increase as opposed to Bioceres Crop Solutions's last price of $6.84. This month's average price target is down -3.70% compared to last quarter, and down -5.45% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 21, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 11, 2024 | Lake Street | Buy | Buy | Hold |
| Sep 11, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Sep 10, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 30, 2022 | Canaccord Genuity | - | Buy | Initialise |
Bioceres Crop Solutions's last stock rating was published by Oppenheimer on Oct 21, 2024. The company gave BIOX a "Outperform" rating, the same as its previous rate.
Bioceres Crop Solutions Financial Forecast
Bioceres Crop Solutions Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $93.61M | $94.55M | $126.84M | $105.75M | $68.23M | $92.31M | $68.23M | $81.05M | $42.11M | $48.00M | $35.54M | $48.13M | $36.23M | $62.27M |
| Avg Forecast | $150.00M | $105.00M | $165.00M | $130.00M | $142.54M | $88.80M | $150.50M | $110.03M | $134.22M | $98.50M | $116.99M | $123.82M | $105.04M | $88.41M | $91.97M | $81.99M | $94.89M | $44.62M | $69.97M | $52.57M | $53.93M | $26.52M | $68.80M | $40.00M | $49.82M | $20.00M | $70.00M |
| High Forecast | $150.00M | $105.00M | $165.00M | $130.00M | $142.54M | $88.80M | $150.50M | $115.05M | $134.22M | $98.50M | $132.81M | $148.75M | $105.04M | $88.41M | $91.97M | $81.99M | $94.89M | $44.62M | $69.97M | $52.57M | $53.93M | $26.52M | $68.80M | $40.00M | $49.82M | $20.00M | $70.00M |
| Low Forecast | $150.00M | $105.00M | $165.00M | $130.00M | $142.54M | $88.80M | $150.50M | $106.17M | $134.22M | $98.50M | $101.62M | $102.42M | $105.04M | $88.41M | $91.97M | $81.99M | $94.89M | $44.62M | $69.97M | $52.57M | $53.93M | $26.52M | $68.80M | $40.00M | $49.82M | $20.00M | $70.00M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 1.03% | 1.55% | 1.11% | 1.53% | 1.32% | 1.30% | 1.50% | 1.59% | 0.70% | 0.89% | 0.97% | 1.81% | 0.89% |
Bioceres Crop Solutions's average Quarter revenue forecast for Jun 23 based on 4 analysts is $105.04M, with a low forecast of $105.04M, and a high forecast of $105.04M. BIOX's average Quarter revenue forecast represents a 12.22% increase compared to the company's last Quarter revenue of $93.61M (Mar 23).
Bioceres Crop Solutions EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.49M | $7.67M | $20.62M | $9.61M | $4.49M | $14.59M | $4.49M | $8.65M | $9.15M | $12.31M | $6.02M | $5.88M | $9.83M | $19.57M |
| Avg Forecast | $28.58M | $20.00M | $31.44M | $24.77M | $27.16M | $16.92M | $28.67M | $20.96M | $25.57M | $18.77M | $22.29M | $23.59M | $20.01M | $16.84M | $17.52M | $15.71M | $18.18M | $-1.29M | $13.41M | $10.07M | $10.33M | $6.88M | $13.18M | $7.66M | $9.55M | $1.30M | $23.71M |
| High Forecast | $28.58M | $20.00M | $31.44M | $24.77M | $27.16M | $16.92M | $28.67M | $21.92M | $25.57M | $18.77M | $25.30M | $28.34M | $20.01M | $16.84M | $17.52M | $15.71M | $18.18M | $-1.03M | $13.41M | $10.07M | $10.33M | $8.26M | $13.18M | $7.66M | $9.55M | $1.56M | $28.45M |
| Low Forecast | $28.58M | $20.00M | $31.44M | $24.77M | $27.16M | $16.92M | $28.67M | $20.23M | $25.57M | $18.77M | $19.36M | $19.51M | $20.01M | $16.84M | $17.52M | $15.71M | $18.18M | $-1.55M | $13.41M | $10.07M | $10.33M | $5.51M | $13.18M | $7.66M | $9.55M | $1.04M | $18.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.75% | 0.44% | 1.31% | 0.53% | -3.48% | 1.09% | 0.45% | 0.84% | 1.33% | 0.93% | 0.79% | 0.62% | 7.57% | 0.83% |
4 analysts predict BIOX's average Quarter EBITDA for Jun 23 to be $20.01M, with a high of $20.01M and a low of $20.01M. This is -32.13% lower than Bioceres Crop Solutions's previous annual EBITDA (Mar 23) of $29.49M.
Bioceres Crop Solutions Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.15M | $-8.43M | $3.91M | $-4.68M | $-6.98M | $5.34M | $-6.98M | $1.38M | $-6.37M | $1.80M | $-624.52K | $3.14M | $-7.98M | $11.31M |
| Avg Forecast | $14.67M | $638.00K | $17.23M | $6.38M | $9.06M | $127.60K | $9.70M | $-1.40M | $14.93M | $10.85M | $5.87M | $5.74M | $1.28M | $-1.66M | $4.47M | $3.06M | $12.69M | $-3.89M | $11.76M | $5.61M | $12.24M | $-1.49M | $18.18M | $5.10M | $13.72M | $-3.69M | $12.00M |
| High Forecast | $14.67M | $638.00K | $17.23M | $6.38M | $9.06M | $127.60K | $9.70M | $4.91M | $15.12M | $10.85M | $8.39M | $9.57M | $1.28M | $-1.66M | $4.47M | $3.06M | $12.69M | $-3.11M | $11.76M | $5.61M | $12.24M | $-1.19M | $18.18M | $5.10M | $13.72M | $-2.95M | $14.40M |
| Low Forecast | $14.67M | $638.00K | $17.23M | $6.38M | $9.06M | $127.60K | $9.70M | $-6.32M | $14.74M | $10.85M | $1.68M | $2.87M | $1.28M | $-1.66M | $4.47M | $3.06M | $12.69M | $-4.67M | $11.76M | $5.61M | $12.24M | $-1.78M | $18.18M | $5.10M | $13.72M | $-4.43M | $9.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -16.97% | -1.89% | 1.28% | -0.37% | 1.79% | 0.45% | -1.24% | 0.11% | 4.28% | 0.10% | -0.12% | 0.23% | 2.16% | 0.94% |
Bioceres Crop Solutions's average Quarter net income forecast for Jun 23 is $1.28M, with a range of $1.28M to $1.28M. BIOX's average Quarter net income forecast represents a -95.47% decrease compared to the company's last Quarter net income of $28.15M (Mar 23).
Bioceres Crop Solutions SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $23.99M | $28.41M | $24.95M | $19.03M | $18.03M | $18.81M | $18.03M | $5.71M | $8.20M | $11.22M | $10.21M | $10.47M | $8.68M | $10.50M |
| Avg Forecast | $28.23M | $19.76M | $31.05M | $24.46M | $26.82M | $16.71M | $28.32M | $20.71M | $25.26M | $18.54M | $22.02M | $23.30M | $19.77M | $16.64M | $17.31M | $15.88M | $18.38M | $8.64M | $13.55M | $10.18M | $10.44M | $12.87M | $13.32M | $7.75M | $9.65M | $10.27M | $11.13M |
| High Forecast | $28.23M | $19.76M | $31.05M | $24.46M | $26.82M | $16.71M | $28.32M | $21.65M | $25.26M | $18.54M | $24.99M | $27.99M | $19.77M | $16.64M | $17.31M | $15.88M | $18.38M | $8.64M | $13.55M | $10.18M | $10.44M | $15.44M | $13.32M | $7.75M | $9.65M | $12.32M | $13.36M |
| Low Forecast | $28.23M | $19.76M | $31.05M | $24.46M | $26.82M | $16.71M | $28.32M | $19.98M | $25.26M | $18.54M | $19.12M | $19.27M | $19.77M | $16.64M | $17.31M | $15.88M | $18.38M | $8.64M | $13.55M | $10.18M | $10.44M | $10.29M | $13.32M | $7.75M | $9.65M | $8.21M | $8.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.44% | 1.64% | 1.57% | 1.04% | 2.09% | 1.39% | 1.77% | 0.55% | 0.64% | 0.84% | 1.32% | 1.09% | 0.85% | 0.94% |
Bioceres Crop Solutions's average Quarter SG&A projection for Jun 23 is $19.77M, based on 4 Wall Street analysts, with a range of $19.77M to $19.77M. The forecast indicates a -17.59% fall compared to BIOX last annual SG&A of $23.99M (Mar 23).
Bioceres Crop Solutions EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.45 | $-0.14 | $0.06 | $-0.10 | $-0.17 | $0.13 | $-0.17 | $0.02 | $-0.18 | $0.02 | $-0.19 | $0.09 | $-0.22 | $0.31 |
| Avg Forecast | $0.23 | $0.01 | $0.27 | $0.10 | $0.14 | - | $0.15 | $-0.02 | $0.23 | $0.17 | $0.09 | $0.09 | $0.02 | $-0.03 | $0.07 | $0.05 | $0.20 | $-0.08 | $0.18 | $0.09 | $0.19 | $-0.04 | $0.28 | $0.08 | $0.21 | $-0.12 | $0.33 |
| High Forecast | $0.23 | $0.01 | $0.27 | $0.10 | $0.14 | - | $0.15 | $0.08 | $0.24 | $0.17 | $0.13 | $0.15 | $0.02 | $-0.03 | $0.07 | $0.05 | $0.20 | $-0.08 | $0.18 | $0.09 | $0.19 | $-0.04 | $0.28 | $0.08 | $0.21 | $-0.12 | $0.33 |
| Low Forecast | $0.23 | $0.01 | $0.27 | $0.10 | $0.14 | - | $0.15 | $-0.10 | $0.23 | $0.17 | $0.03 | $0.04 | $0.02 | $-0.03 | $0.07 | $0.05 | $0.20 | $-0.08 | $0.18 | $0.09 | $0.19 | $-0.04 | $0.28 | $0.08 | $0.21 | $-0.12 | $0.33 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -17.31% | -2.00% | 1.35% | -0.50% | 2.17% | 0.71% | -1.93% | 0.11% | 4.44% | 0.06% | -2.38% | 0.40% | 1.91% | 0.94% |
According to 4 Wall Street analysts, Bioceres Crop Solutions's projected average Quarter EPS for Jun 23 is $0.02, with a low estimate of $0.02 and a high estimate of $0.02. This represents a -95.56% decrease compared to BIOX previous annual EPS of $0.45 (Mar 23).
Bioceres Crop Solutions Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AVD | American Vanguard | $6.43 | $20.00 | 211.04% | Buy |
| BIOX | Bioceres Crop Solutions | $6.84 | $13.30 | 94.44% | Buy |
| FMC | FMC | $55.73 | $92.56 | 66.09% | Buy |
| ICL | ICL Group | $4.30 | $7.07 | 64.42% | Hold |
| MOS | Mosaic Company | $26.12 | $39.67 | 51.88% | Buy |
| LVRO | Lavoro | $4.99 | $6.50 | 30.26% | Buy |
| CF | CF Industries | $85.21 | $103.11 | 21.01% | Buy |
| CTVA | Corteva | $57.66 | $66.95 | 16.11% | Buy |
| IPI | Intrepid Potash | $27.40 | $31.50 | 14.96% | Hold |